Ares Investments's most recent trade in Jagsonpal Pharmaceuticals Ltd. was a Disposal of 11,455,500 Equity Shares done at an average price of Rs. 235 . Disclosure was reported to the exchange on June 29, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Ares Investments in the Trendlyne database.